AstraZeneca joins Trump’s drug pricing plan, pledging $50bn US investment and discounts of up to 80% to cut prescription medicine costs.

The UK’s NIHR has invested £1.5M in digital health to cut paediatric mental health waiting times.

A new biotech company in New York, Nilo Therapeutics, believes the brain could hold the key to treating immune diseases.

ABPI calls for NICE to raise its cost effectiveness threshold for new medicine, which hasn’t raised in 20 years and is not linked to inflation.

New research from Precision Neuroscience shows its brain-computer interface can record high-resolution signals without invasive surgery.

UK pharma and healthcare stocks drive FTSE 100 to a record high, led by AstraZeneca, as trade policy shifts boost investor confidence.

Read this month’s pharma news roundup, featuring AI in healthcare risks, GLP-1 drug trials beyond obesity and Trump’s US tariffs.

England’s NHS is launching NHS Online, a fully digital hospital, to speed up specialist appointments, cut wait times and improve care access.